Ars Technica on Nostr: Neuralink says it has the FDA’s OK to start clinical trials Company isn't enrolling ...
Published at
2023-05-26 00:12:27Event JSON
{
"id": "b211848aad7036e8c0f542fe48d502c4d5491cd5c7ee5978330289e93747cfcb",
"pubkey": "509c345f0518ca1421ba9f26a98ac6b0b6f884b1874ed9c20320fd41158313e4",
"created_at": 1685059947,
"kind": 1,
"tags": [
[
"mostr",
"https://mastodon.social/users/arstechnica/statuses/110432088695152143"
]
],
"content": "Neuralink says it has the FDA’s OK to start clinical trials\n\nCompany isn't enrolling patients yet, but has cleared a major hurdle.\n\nhttps://arstechnica.com/science/2023/05/neuralink-says-it-has-the-fdas-ok-to-start-clinical-trials/?utm_brand=arstechnica\u0026utm_social-type=owned\u0026utm_source=mastodon\u0026utm_medium=social\n\nhttps://files.mastodon.social/media_attachments/files/110/432/088/389/369/911/original/4c58aefc4223060f.jpg",
"sig": "dd68fcb49049917118c3ec5ea7b73f1e486fb17f93b1030ac51e7c7bb07490e43982308ff2c6eb16eb4bc3185a4d7894024cd763869224f3d32bb99a3e38aff0"
}
